Tolosa-Hunt syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:64686H49.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tolosa-Hunt syndrome (THS) is a rare condition that causes painful inflammation behind or around the eye socket (the bony cavity that holds the eye). This inflammation affects a specific area called the cavernous sinus or the superior orbital fissure — narrow passages through which important nerves and blood vessels travel to and from the eye. When these nerves become inflamed, they can no longer work properly, leading to the hallmark symptoms of the disease. The most recognizable symptoms are severe, stabbing or boring pain around one eye, combined with double vision or drooping of the eyelid. These happen because the nerves that control eye movement and the eyelid become compressed or irritated by the inflamed tissue. Symptoms usually affect only one side of the face. The condition can come and go, with episodes lasting days to weeks if untreated. The good news is that Tolosa-Hunt syndrome typically responds very well to corticosteroid medications, such as prednisone. Most people experience dramatic pain relief within 24 to 72 hours of starting treatment. However, relapses can occur, and long-term monitoring is important. Because THS is rare and its symptoms overlap with other serious conditions, getting the right diagnosis can take time. It is sometimes also called painful ophthalmoplegia, referring to the combination of eye pain and paralysis of eye muscles.

Also known as:

Key symptoms:

Severe, stabbing or aching pain around or behind one eyeDouble vision (seeing two images instead of one)Drooping of the upper eyelid (ptosis)Inability to move the eye normally in one or more directionsNumbness or tingling around the forehead or eye areaPupil that is larger or smaller than normalPain that spreads to the forehead or templeSymptoms affecting only one side of the faceEpisodes that come and go over time (relapsing course)

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tolosa-Hunt syndrome.

View clinical trials →

No actively recruiting trials found for Tolosa-Hunt syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tolosa-Hunt syndrome community →

No specialists are currently listed for Tolosa-Hunt syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tolosa-Hunt syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tolosa-Hunt syndromeForum →

No community posts yet. Be the first to share your experience with Tolosa-Hunt syndrome.

Start the conversation →

Latest news about Tolosa-Hunt syndrome

No recent news articles for Tolosa-Hunt syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How confident are you in the diagnosis of Tolosa-Hunt syndrome, and what other conditions have been ruled out?,How long will I need to take corticosteroids, and how will we taper the dose safely?,What are the warning signs that my symptoms are returning, and when should I call you or go to the emergency room?,How likely am I to have a relapse, and what is the plan if my symptoms come back?,Will my double vision or eyelid drooping fully recover, and how long might that take?,Are there any long-term risks from repeated steroid use, and are there alternative treatments if I relapse frequently?,Should I see a neuro-ophthalmologist in addition to a neurologist for ongoing care?

Common questions about Tolosa-Hunt syndrome

What is Tolosa-Hunt syndrome?

Tolosa-Hunt syndrome (THS) is a rare condition that causes painful inflammation behind or around the eye socket (the bony cavity that holds the eye). This inflammation affects a specific area called the cavernous sinus or the superior orbital fissure — narrow passages through which important nerves and blood vessels travel to and from the eye. When these nerves become inflamed, they can no longer work properly, leading to the hallmark symptoms of the disease. The most recognizable symptoms are severe, stabbing or boring pain around one eye, combined with double vision or drooping of the eyeli

How is Tolosa-Hunt syndrome inherited?

Tolosa-Hunt syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tolosa-Hunt syndrome typically begin?

Typical onset of Tolosa-Hunt syndrome is adult. Age of onset can vary across affected individuals.